# Thorough QT/QTc of Pritelivir in Healthy Subjects

> **NCT05671029** · PHASE1 · COMPLETED · sponsor: **AiCuris Anti-infective Cures AG** · enrollment: 64 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Pritelivir and moxifloxacin placebo
- **DRUG:** Pritelivir placebo, moxifloxacin and moxifloxacin placebo
- **DRUG:** Pritelivir placebo, moxifloxacin placebo and moxifloxacin

## Key facts

- **NCT ID:** NCT05671029
- **Lead sponsor:** AiCuris Anti-infective Cures AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-04
- **Primary completion:** 2023-05-18
- **Final completion:** 2023-05-18
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2025-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05671029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05671029, "Thorough QT/QTc of Pritelivir in Healthy Subjects". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT05671029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*